查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594484

神经血管设备市场：按类型、应用分类 - 2025-2030 年全球预测

Neurovascular Neurology Devices Market by Type, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年神经血管器械市场规模为30亿美元，预计2024年将达32.3亿美元，复合年增长率为7.79%，2030年将达50.8亿美元。

神经血管设备市场包括各种旨在诊断和治疗中枢神经系统（CNS）内血管疾病的技术，包括中风、动脉瘤和动静脉畸形等疾病。由于人口老化和生活方式相关危险因子导致中枢神经系统血管疾病的盛行率不断增加，这些设备变得至关重要。常见应用包括微创手术、栓塞、支架置入术和血栓切​​除术，主要用于需要专门神经科护理的医院、神经科诊所和门诊手术中心。主要成长动力包括对神经血管疾病早期疗育意识的提高，以及人工智慧整合成像系统和机器人等技术进步。在更广泛的医疗保健和经济成长的推动下，亚太和拉丁美洲的新兴市场正在经历不断扩大的成长机会。利用这些机会的建议包括策略伙伴关係、对当地製造业的投资以及与不同区域卫生基础设施一致的个人化医疗解决方案。

主要市场统计
基准年[2023] 30亿美元
预测年份 [2024] 32.3亿美元
预测年份 [2030] 50.8亿美元
复合年增长率（%） 7.79%

儘管潜力巨大，但该市场仍面临挑战，包括严格的监管要求、与开拓先进技术相关的高成本以及缺乏接受过介入神经放射学手术培训的熟练医疗保健专业人员。此外，发展中地区的经济差异对先进的神经血管治疗造成了财务障碍。在创新和研究方面，重点领域包括透过人工智慧和机器学习来提高设备准确性、开发生物可吸收支架以及改进非侵入性诊断技术。远距神经病学创新还有可能扩大偏远地区获得优质照护的机会。该行业的特点是技术进步快、併购频繁，注重产品的不断改进和市场的拓展，保持活力和适度的竞争。这表明，专注于数位健康平台和基于证据的现实世界结果的公司有潜力在不断变化的环境中定位自己，最终改善患者照护和市场成长。

市场动态：揭示快速发展的神经血管设备市场的关键市场洞察

供需的动态交互作用正在改变神经血管设备市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 神经系统疾病发生率增加
    • 高血压、饮酒和吸烟的盛行率增加
    • 微创手术需求不断成长
  • 市场限制因素
    • 缺乏熟练的神经外科医生
  • 市场机会
    • 神经血管设备的技术进步迅速成长
    • 采用先进的血栓清除技术
  • 市场挑战
    • 神经血管手术费用高

波特五力：驾驭神经血管设备市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解神经血管设备市场的外部影响

外部宏观环境因素在塑造神经血管设备市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解神经血管设备市场的竞争格局

对神经血管设备市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵神经血管设备市场供应商的绩效评估

FPNV定位矩阵是评估神经血管设备市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划神经血管设备市场的成功之路

神经血管设备市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 神经系统疾病发生率增加
      • 高血压、饮酒和吸烟增加
      • 微创手术需求增加
    • 抑制因素
      • 缺乏熟练的神经外科医生
    • 机会
      • 神经血管设备的技术进步迅速成长
      • 采用先进的血栓清除技术
    • 任务
      • 神经血管手术的手术费用高
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章神经血管设备市场：依类型

  • 颈动脉支架系统
  • 脑动脉瘤及动静脉畸形血管内栓塞系统
  • 脑血栓清除器
  • 动脉瘤分流器
  • 颅内支架系统

第七章神经血管设备市场：依应用分类

  • 脑动脉瘤
  • 脑动脉狭窄
  • 中风

第八章美洲神经血管设备市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区神经血管器材市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第10章欧洲、中东和非洲的神经血管设备市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Balt USA LLC
  • Evasc Medical Systems Corp.
  • Integer Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Kaneka Corp.
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Phenox GmbH
  • Rapid Medical Ltd.
  • Sensome
  • Stryker Corporation
  • Terumo Corporation
Product Code: MRR-036C5CF3B4E4

The Neurovascular Neurology Devices Market was valued at USD 3.00 billion in 2023, expected to reach USD 3.23 billion in 2024, and is projected to grow at a CAGR of 7.79%, to USD 5.08 billion by 2030.

The neurovascular neurology devices market encompasses a range of technologies designed to diagnose and treat vascular disorders within the central nervous system (CNS), including conditions such as stroke, aneurysms, and arteriovenous malformations. These devices are vital due to the increasing prevalence of CNS vascular diseases, driven by an aging population and lifestyle-related risk factors. Common applications include minimally invasive procedures, embolization, stenting, and thrombectomy, utilized primarily by hospitals, neurology clinics, and ambulatory surgical centers where specialized neurological care is required. Key growth drivers include technological advancements, such as AI-integrated imaging systems and robotics, alongside rising awareness about early intervention in neurovascular disorders. Opportunities are expanding with emerging markets in Asia-Pacific and Latin America, propelled by broader healthcare access and economic growth. Recommendations to capitalize on these opportunities include strategic partnerships, investment in local manufacturing, and personalized medical solutions catering to diverse regional health infrastructures.

KEY MARKET STATISTICS
Base Year [2023] USD 3.00 billion
Estimated Year [2024] USD 3.23 billion
Forecast Year [2030] USD 5.08 billion
CAGR (%) 7.79%

Despite its potential, the market faces challenges including stringent regulatory requirements, high costs associated with advanced technology development, and a shortage of skilled healthcare professionals trained in neurointerventional procedures. Additionally, the economic discrepancies in developing regions pose financial barriers to advanced neurovascular care. For innovation and research, focus areas include enhancing device accuracy through AI and machine learning, developing bioabsorbable stents, and improving non-invasive diagnostic techniques. Innovations in tele-neurology could also expand access to quality care in remote areas. The industry remains dynamic and moderately competitive, characterized by rapid technological advancements and frequent mergers or acquisitions, focusing on continual product enhancement and market expansion. Insight into this nature suggests that companies focusing on digital health platforms and real-world, evidence-based outcomes could position themselves strongly in the evolving landscape, ultimately leading to enhanced patient care and market growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neurovascular Neurology Devices Market

The Neurovascular Neurology Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in the incidence of neurological disorders
    • Increasing prevalence of hypertension, alcohol consumption, and smoking
    • Rising demand for minimally invasive surgical procedures
  • Market Restraints
    • Lack of skilled neurosurgeons
  • Market Opportunities
    • Surge in technological advancements related to neurovascular devices
    • Adoption of advances in thrombectomy technologies
  • Market Challenges
    • High procedural cost of neurovascular surgeries

Porter's Five Forces: A Strategic Tool for Navigating the Neurovascular Neurology Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neurovascular Neurology Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neurovascular Neurology Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neurovascular Neurology Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neurovascular Neurology Devices Market

A detailed market share analysis in the Neurovascular Neurology Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neurovascular Neurology Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neurovascular Neurology Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neurovascular Neurology Devices Market

A strategic analysis of the Neurovascular Neurology Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neurovascular Neurology Devices Market, highlighting leading vendors and their innovative profiles. These include Balt USA LLC, Evasc Medical Systems Corp., Integer Holdings Corporation, Johnson & Johnson Services, Inc., Kaneka Corp., Medtronic PLC, MicroPort Scientific Corporation, Penumbra, Inc., Phenox GmbH, Rapid Medical Ltd., Sensome, Stryker Corporation, and Terumo Corporation.

Market Segmentation & Coverage

This research report categorizes the Neurovascular Neurology Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Carotid Artery Stenting System, Cerebral Aneurysm & AVM Endovascular Embolization Systems, Cerebral Thrombectomy Devices, Flow Diverter for Aneurysm, and Intracranial Stent Systems.
  • Based on Application, market is studied across Cerebral Aneurysm, Cerebral Artery Stenosis, and Stroke.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the incidence of neurological disorders
      • 5.1.1.2. Increasing prevalence of hypertension, alcohol consumption, and smoking
      • 5.1.1.3. Rising demand for minimally invasive surgical procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled neurosurgeons
    • 5.1.3. Opportunities
      • 5.1.3.1. Surge in technological advancements related to neurovascular devices
      • 5.1.3.2. Adoption of advances in thrombectomy technologies
    • 5.1.4. Challenges
      • 5.1.4.1. High procedural cost of neurovascular surgeries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Neurovascular Neurology Devices Market, by Type

  • 6.1. Introduction
  • 6.2. Carotid Artery Stenting System
  • 6.3. Cerebral Aneurysm & AVM Endovascular Embolization Systems
  • 6.4. Cerebral Thrombectomy Devices
  • 6.5. Flow Diverter for Aneurysm
  • 6.6. Intracranial Stent Systems

7. Neurovascular Neurology Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Cerebral Aneurysm
  • 7.3. Cerebral Artery Stenosis
  • 7.4. Stroke

8. Americas Neurovascular Neurology Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Neurovascular Neurology Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Neurovascular Neurology Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Balt USA LLC
  • 2. Evasc Medical Systems Corp.
  • 3. Integer Holdings Corporation
  • 4. Johnson & Johnson Services, Inc.
  • 5. Kaneka Corp.
  • 6. Medtronic PLC
  • 7. MicroPort Scientific Corporation
  • 8. Penumbra, Inc.
  • 9. Phenox GmbH
  • 10. Rapid Medical Ltd.
  • 11. Sensome
  • 12. Stryker Corporation
  • 13. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. NEUROVASCULAR NEUROLOGY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. NEUROVASCULAR NEUROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. NEUROVASCULAR NEUROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEUROVASCULAR NEUROLOGY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NEUROVASCULAR NEUROLOGY DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CAROTID ARTERY STENTING SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL ANEURYSM & AVM ENDOVASCULAR EMBOLIZATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL THROMBECTOMY DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTER FOR ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INTRACRANIAL STENT SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL ANEURYSM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY CEREBRAL ARTERY STENOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STROKE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NEUROVASCULAR NEUROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 104. NEUROVASCULAR NEUROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2023